These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 28449421)

  • 41. Using Blood and Plasma MicroRNAs as a Non-Invasive Biomarker in Patients with Colorectal Cancer.
    Stefanescu H; Muntean D; Pilut C; Diaconu M; Popescu R; Hutanu D; Moise M; Diana L; Nitu R; Cherecheanu AP; Negoita S; Iovan CV; Ungureanu E; Calu V; Ciuca I
    Clin Lab; 2018 Mar; 64(3):257-262. PubMed ID: 29739108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of micro RNAs in the diagnosis and prognosis of colorectal cancer (CCR)].
    Arredondo-Valdez AR; Wence-Chavez L; Rosales-Reynoso MA
    Gac Med Mex; 2016; 152(3):386-96. PubMed ID: 27335196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. One step ahead: miRNA-34 in colon cancer-future diagnostic and therapeutic tool?
    Krajewska JB; Fichna J; Mosińska P
    Crit Rev Oncol Hematol; 2018 Dec; 132():1-8. PubMed ID: 30447913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
    Wu X; Xu X; Li S; Wu S; Chen R; Jiang Q; Liu H; Sun Y; Li Y; Xu Y
    PLoS One; 2015; 10(3):e0120024. PubMed ID: 25803870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNAs in colorectal cancer: small molecules with big functions.
    Xuan Y; Yang H; Zhao L; Lau WB; Lau B; Ren N; Hu Y; Yi T; Zhao X; Zhou S; Wei Y
    Cancer Lett; 2015 May; 360(2):89-105. PubMed ID: 25524553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNAs in gastric cancer: Biomarkers and therapeutic targets.
    Ghafouri-Fard S; Vafaee R; Shoorei H; Taheri M
    Gene; 2020 Oct; 757():144937. PubMed ID: 32640300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [SIGNIFICANCE OF NONCODING RNAS IN COLORECTAL CANCER: REVIEW].
    Toiyama Y; Kusunoki M
    Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):360-5. PubMed ID: 26845887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application.
    Slaby O; Svoboda M; Michalek J; Vyzula R
    Mol Cancer; 2009 Nov; 8():102. PubMed ID: 19912656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.
    Jafri MA; Zaidi SK; Ansari SA; Al-Qahtani MH; Shay JW
    Expert Opin Ther Targets; 2015; 19(12):1705-23. PubMed ID: 26189482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systematic analysis of key miRNAs and related signaling pathways in colorectal tumorigenesis.
    Yin Y; Song M; Gu B; Qi X; Hu Y; Feng Y; Liu H; Zhou L; Bian Z; Zhang J; Zuo X; Huang Z
    Gene; 2016 Mar; 578(2):177-84. PubMed ID: 26692142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Examining plasma microRNA markers for colorectal cancer at different stages.
    Sun Y; Liu Y; Cogdell D; Calin GA; Sun B; Kopetz S; Hamilton SR; Zhang W
    Oncotarget; 2016 Mar; 7(10):11434-49. PubMed ID: 26863633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
    Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
    Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-21 as a potential colon and rectal cancer biomarker.
    Li T; Leong MH; Harms B; Kennedy G; Chen L
    World J Gastroenterol; 2013 Sep; 19(34):5615-21. PubMed ID: 24039353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression profile, molecular functions, and prognostic significance of miRNAs in primary colorectal cancer stem cells.
    Fan CW; Lu R; Fang C; Zhang XL; Lv ZY; Li Y; Zhang H; Zhou ZG; Mo XM; Sun XF
    Aging (Albany NY); 2021 Apr; 13(8):12067-12085. PubMed ID: 33793420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miRNAs as biomarkers in colorectal cancer diagnosis and prognosis.
    Ju J
    Bioanalysis; 2010 May; 2(5):901-6. PubMed ID: 20543966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-223 functions as an oncogene in human colorectal cancer cells.
    Zhang J; Luo X; Li H; Yue X; Deng L; Cui Y; Lu Y
    Oncol Rep; 2014 Jul; 32(1):115-20. PubMed ID: 24819398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
    Yang Y; Du Y; Liu X; Cho WC
    Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications.
    Strubberg AM; Madison BB
    Dis Model Mech; 2017 Mar; 10(3):197-214. PubMed ID: 28250048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.